Spotlight
Featured
Commercialising university research: insights from AlbionVC’s Dave Grimm
In this Infinite Frontiers conversation, AlbionVC Partner Dave Grimm explores why Europe lags in commercialising research, how deep tech spinouts can scale from lab to market, and what founders, investors and universities must do to build the next generation of breakthrough companies.
Entrepreneur Magazine: Why London’s tech ecosystem continues to lead – and why that’s good for Europe
AlbionVC Partner Ed Lascelles explores why London remains the continent’s deep tech powerhouse — and why it’s only getting stronger
Simon Goldman on transforming hard science into global impact – Podcast
Simon Goldman on transforming hard science into global impact
What's happening in biotech?
On not downclimbing – the prospects for early stage biotech remain bright
Bringing immuno-oncology cell therapies to the masses – are we (nearly) there yet?
Will the boom last?
A window to the past: is the investment boom in biotech going to last?
On the UK biotech public market
